Radiant Innovation
Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors. The company also offers industrial infrared thermometers, infrared precision thermal imagers, infrared precision… Read more
Radiant Innovation (3373) - Net Assets
Latest net assets as of September 2025: NT$787.92 Million TWD
Based on the latest financial reports, Radiant Innovation (3373) has net assets worth NT$787.92 Million TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$852.27 Million) and total liabilities (NT$64.36 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$787.92 Million |
| % of Total Assets | 92.45% |
| Annual Growth Rate | 3.73% |
| 5-Year Change | -35.71% |
| 10-Year Change | N/A |
| Growth Volatility | 39.53 |
Radiant Innovation - Net Assets Trend (2017–2024)
This chart illustrates how Radiant Innovation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Radiant Innovation (2017–2024)
The table below shows the annual net assets of Radiant Innovation from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$865.89 Million | -6.50% |
| 2023-12-31 | NT$926.06 Million | -9.34% |
| 2022-12-31 | NT$1.02 Billion | -4.34% |
| 2021-12-31 | NT$1.07 Billion | -20.71% |
| 2020-12-31 | NT$1.35 Billion | +104.44% |
| 2019-12-31 | NT$658.75 Million | -1.11% |
| 2018-12-31 | NT$666.12 Million | -0.57% |
| 2017-12-31 | NT$669.96 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Radiant Innovation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 133.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$186.88 Million | 21.58% |
| Other Components | NT$679.02 Million | 78.42% |
| Total Equity | NT$865.89 Million | 100.00% |
Radiant Innovation Competitors by Market Cap
The table below lists competitors of Radiant Innovation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eurotech S.p.A.
LSE:0E7Z
|
$18.66 Million |
|
Stalprofil S.A.
WAR:STF
|
$18.66 Million |
|
Wolford AG
LSE:0GJA
|
$18.66 Million |
|
Wolford Aktiengesellschaft
VI:WOL
|
$18.66 Million |
|
Unifosa
TWO:8277
|
$18.65 Million |
|
Seyitler Kimya Sanayi AS
IS:SEYKM
|
$18.64 Million |
|
Mulia Boga Raya PT
JK:KEJU
|
$18.64 Million |
|
Laird Superfood Inc
NYSE MKT:LSF
|
$18.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Radiant Innovation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 926,064,000 to 865,894,000, a change of -60,170,000 (-6.5%).
- Net loss of 28,577,000 reduced equity.
- Dividend payments of 43,290,000 reduced retained earnings.
- Other factors increased equity by 11,697,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-28.58 Million | -3.3% |
| Dividends Paid | NT$43.29 Million | -5.0% |
| Other Changes | NT$11.70 Million | +1.35% |
| Total Change | NT$- | -6.50% |
Book Value vs Market Value Analysis
This analysis compares Radiant Innovation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.94x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.11x to 0.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | NT$15.48 | NT$17.15 | x |
| 2018-12-31 | NT$15.39 | NT$17.15 | x |
| 2019-12-31 | NT$15.22 | NT$17.15 | x |
| 2020-12-31 | NT$31.11 | NT$17.15 | x |
| 2021-12-31 | NT$24.67 | NT$17.15 | x |
| 2022-12-31 | NT$23.60 | NT$17.15 | x |
| 2023-12-31 | NT$19.45 | NT$17.15 | x |
| 2024-12-31 | NT$18.18 | NT$17.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Radiant Innovation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.30%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.80%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 1.08x
- Recent ROE (-3.30%) is below the historical average (8.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 1.98% | 1.72% | 0.96x | 1.20x | NT$-53.71 Million |
| 2018 | 2.14% | 1.75% | 1.02x | 1.20x | NT$-52.38 Million |
| 2019 | 4.37% | 3.66% | 1.00x | 1.19x | NT$-37.11 Million |
| 2020 | 54.68% | 28.14% | 1.36x | 1.43x | NT$601.67 Million |
| 2021 | 10.53% | 11.42% | 0.79x | 1.16x | NT$5.69 Million |
| 2022 | 2.81% | 5.08% | 0.51x | 1.09x | NT$-73.49 Million |
| 2023 | -5.27% | -11.65% | 0.43x | 1.06x | NT$-141.37 Million |
| 2024 | -3.30% | -6.80% | 0.45x | 1.08x | NT$-115.17 Million |
Industry Comparison
This section compares Radiant Innovation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,319,583,333
- Average return on equity (ROE) among peers: 7.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Radiant Innovation (3373) | NT$787.92 Million | 1.98% | 0.08x | $18.65 Million |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |